JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy, today announced that it has entered into a strategic partnership with MediTrust Health. Leveraging the respective business advantages, both parties plan to strengthen cooperation in supplementary medical insurance and health insurance policy, to relieve the payment burden of patients […]
The post JW Therapeutics Announces Strategic Partnership with MediTrust Health appeared first on ThaiPR.NET.
Source: ThaiPR
